Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Par Pharmaceutical is a leading American pharmaceutical company that specializes in the development, manufacturing, and distribution of high-barrier-to-entry generic and specialty drug products. As a major subsidiary of Endo International, the company operates through several divisions, including Par Sterile Products and Par Specialty Pharmaceuticals, focusing on complex dosage forms such as injectables and high-potency orals. Par is well-known for its extensive portfolio of generic medicines, including critical care products like Vasostrict and Adrenalin, which are widely used in hospital settings. The company maintains a robust pipeline of Abbreviated New Drug Applications (ANDAs) and continues to be a significant player in the U.S. generic drug market despite the financial restructuring of its parent organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PAR Technology.